Serum intact fibroblast growth factor 23 in healthy paediatric population

It is believed that fibroblast growth factor 23 (FGF23) can become an early biomarker of chronic kidney disease progression. Data on FGF23 age dependency are inconsistent. We present the results of the cross-sectional study concerning FGF23 levels in healthy Polish children. This study was conducted...

Full description

Saved in:
Bibliographic Details
Published in:Open medicine (Warsaw, Poland) Poland), 2021-07, Vol.16 (1), p.1022-1027
Main Authors: Stanczyk, Malgorzata, Chrul, Slawomir, Wyka, Krystyna, Tkaczyk, Marcin
Format: Article
Language:English
Subjects:
Age groups
child
fibroblast growth factors
Fibroblasts
Growth factors
Pediatrics
renal insufficiency
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c464t-2360feaa94858d3a10b8b79fca1ee0fb5491d7069dfe404023e26a9b163cfae73
cites cdi_FETCH-LOGICAL-c464t-2360feaa94858d3a10b8b79fca1ee0fb5491d7069dfe404023e26a9b163cfae73
container_end_page 1027
container_issue 1
container_start_page 1022
container_title Open medicine (Warsaw, Poland)
container_volume 16
creator Stanczyk, Malgorzata
Chrul, Slawomir
Wyka, Krystyna
Tkaczyk, Marcin
description It is believed that fibroblast growth factor 23 (FGF23) can become an early biomarker of chronic kidney disease progression. Data on FGF23 age dependency are inconsistent. We present the results of the cross-sectional study concerning FGF23 levels in healthy Polish children. This study was conducted in 121 children aged 0-18 years. Kidney function and intact FGF23 levels in serum were assessed. Differences between age groups and according to gender were analysed. The difference in FGF23 between age groups and according to gender was statistically insignificant. In the youngest and the oldest group, a trend to higher FGF23 levels was observed. FGF23 level in girls tended to be higher than boys, apart from the age group between 1 and 4 years. There was a negative correlation between eGFR and FGF23 ( = -0.26, < 0.05) - strong in girls ( = -0.38, < 0.05), but not in boys. In each age group, we found no significant correlation between eGFR and FGF23. Our study supports the evidence that the FGF23 level in paediatric population is not age or sex dependent. The results can serve as a reference point under clinical conditions and for other studies on the topic.
doi_str_mv 10.1515/med-2021-0288
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_477ff00ad189485c8eae4f3d91cf778b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_477ff00ad189485c8eae4f3d91cf778b</doaj_id><sourcerecordid>2548741532</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-2360feaa94858d3a10b8b79fca1ee0fb5491d7069dfe404023e26a9b163cfae73</originalsourceid><addsrcrecordid>eNptkU2LFDEQhhtR3GXdo1dp8OKlNV_dSUAEWfwYWPCgnkN1ujKToafTJmmX-femnXXdFU8pkoe3KvVU1XNKXtOWtm8OODSMMNoQptSj6pxxTZtWdPzxvfqsukxpTwihLZdakqfVGResVVyz82rzFeNyqP2Uweba-T6GfoSU620MN3lXu3IdYs14Qeodwph3x3oGHDzk6G09h3kZIfswPaueOBgTXt6eF9X3jx--XX1urr982ly9v26s6ERuGO-IQwAtVKsGDpT0qpfaWaCIxPWt0HSQpNODQ0EEYRxZB7qnHbcOUPKLanPKHQLszRz9AeLRBPDm90WIWwMxezuiEVI6RwgMVK3trEJA4figqXVSqr5kvTtlzUtfdmlxyhHGB6EPXya_M9vw0yjWsZbqEvDqNiCGHwumbA4-WRxHmDAsybC2aJKqYyv68h90H5Y4lVUVSigpih5WqOZE2RhSiujuhqHErM5Nmcaszs3qvPAv7v_gjv5juABvT8BNcYdxwG1cjqX42_2_wbSjlDDGfwGIabsp</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2548741532</pqid></control><display><type>article</type><title>Serum intact fibroblast growth factor 23 in healthy paediatric population</title><source>PubMed Central</source><source>Walter De Gruyter: Open Access Journals</source><creator>Stanczyk, Malgorzata ; Chrul, Slawomir ; Wyka, Krystyna ; Tkaczyk, Marcin</creator><creatorcontrib>Stanczyk, Malgorzata ; Chrul, Slawomir ; Wyka, Krystyna ; Tkaczyk, Marcin</creatorcontrib><description>It is believed that fibroblast growth factor 23 (FGF23) can become an early biomarker of chronic kidney disease progression. Data on FGF23 age dependency are inconsistent. We present the results of the cross-sectional study concerning FGF23 levels in healthy Polish children. This study was conducted in 121 children aged 0-18 years. Kidney function and intact FGF23 levels in serum were assessed. Differences between age groups and according to gender were analysed. The difference in FGF23 between age groups and according to gender was statistically insignificant. In the youngest and the oldest group, a trend to higher FGF23 levels was observed. FGF23 level in girls tended to be higher than boys, apart from the age group between 1 and 4 years. There was a negative correlation between eGFR and FGF23 ( = -0.26, &lt; 0.05) - strong in girls ( = -0.38, &lt; 0.05), but not in boys. In each age group, we found no significant correlation between eGFR and FGF23. Our study supports the evidence that the FGF23 level in paediatric population is not age or sex dependent. The results can serve as a reference point under clinical conditions and for other studies on the topic.</description><identifier>ISSN: 2391-5463</identifier><identifier>EISSN: 2391-5463</identifier><identifier>DOI: 10.1515/med-2021-0288</identifier><identifier>PMID: 34258392</identifier><language>eng</language><publisher>Poland: De Gruyter</publisher><subject>Age groups ; child ; fibroblast growth factors ; Fibroblasts ; Growth factors ; Pediatrics ; renal insufficiency</subject><ispartof>Open medicine (Warsaw, Poland), 2021-07, Vol.16 (1), p.1022-1027</ispartof><rights>2021 Malgorzata Stanczyk et al., published by De Gruyter.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Malgorzata Stanczyk ., published by De Gruyter 2021 Malgorzata Stanczyk et al., published by De Gruyter</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-2360feaa94858d3a10b8b79fca1ee0fb5491d7069dfe404023e26a9b163cfae73</citedby><cites>FETCH-LOGICAL-c464t-2360feaa94858d3a10b8b79fca1ee0fb5491d7069dfe404023e26a9b163cfae73</cites><orcidid>0000-0001-6613-1642</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262519/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262519/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771,66904,68688</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34258392$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stanczyk, Malgorzata</creatorcontrib><creatorcontrib>Chrul, Slawomir</creatorcontrib><creatorcontrib>Wyka, Krystyna</creatorcontrib><creatorcontrib>Tkaczyk, Marcin</creatorcontrib><title>Serum intact fibroblast growth factor 23 in healthy paediatric population</title><title>Open medicine (Warsaw, Poland)</title><addtitle>Open Med (Wars)</addtitle><description>It is believed that fibroblast growth factor 23 (FGF23) can become an early biomarker of chronic kidney disease progression. Data on FGF23 age dependency are inconsistent. We present the results of the cross-sectional study concerning FGF23 levels in healthy Polish children. This study was conducted in 121 children aged 0-18 years. Kidney function and intact FGF23 levels in serum were assessed. Differences between age groups and according to gender were analysed. The difference in FGF23 between age groups and according to gender was statistically insignificant. In the youngest and the oldest group, a trend to higher FGF23 levels was observed. FGF23 level in girls tended to be higher than boys, apart from the age group between 1 and 4 years. There was a negative correlation between eGFR and FGF23 ( = -0.26, &lt; 0.05) - strong in girls ( = -0.38, &lt; 0.05), but not in boys. In each age group, we found no significant correlation between eGFR and FGF23. Our study supports the evidence that the FGF23 level in paediatric population is not age or sex dependent. The results can serve as a reference point under clinical conditions and for other studies on the topic.</description><subject>Age groups</subject><subject>child</subject><subject>fibroblast growth factors</subject><subject>Fibroblasts</subject><subject>Growth factors</subject><subject>Pediatrics</subject><subject>renal insufficiency</subject><issn>2391-5463</issn><issn>2391-5463</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkU2LFDEQhhtR3GXdo1dp8OKlNV_dSUAEWfwYWPCgnkN1ujKToafTJmmX-femnXXdFU8pkoe3KvVU1XNKXtOWtm8OODSMMNoQptSj6pxxTZtWdPzxvfqsukxpTwihLZdakqfVGResVVyz82rzFeNyqP2Uweba-T6GfoSU620MN3lXu3IdYs14Qeodwph3x3oGHDzk6G09h3kZIfswPaueOBgTXt6eF9X3jx--XX1urr982ly9v26s6ERuGO-IQwAtVKsGDpT0qpfaWaCIxPWt0HSQpNODQ0EEYRxZB7qnHbcOUPKLanPKHQLszRz9AeLRBPDm90WIWwMxezuiEVI6RwgMVK3trEJA4figqXVSqr5kvTtlzUtfdmlxyhHGB6EPXya_M9vw0yjWsZbqEvDqNiCGHwumbA4-WRxHmDAsybC2aJKqYyv68h90H5Y4lVUVSigpih5WqOZE2RhSiujuhqHErM5Nmcaszs3qvPAv7v_gjv5juABvT8BNcYdxwG1cjqX42_2_wbSjlDDGfwGIabsp</recordid><startdate>20210706</startdate><enddate>20210706</enddate><creator>Stanczyk, Malgorzata</creator><creator>Chrul, Slawomir</creator><creator>Wyka, Krystyna</creator><creator>Tkaczyk, Marcin</creator><general>De Gruyter</general><general>Walter de Gruyter GmbH</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-6613-1642</orcidid></search><sort><creationdate>20210706</creationdate><title>Serum intact fibroblast growth factor 23 in healthy paediatric population</title><author>Stanczyk, Malgorzata ; Chrul, Slawomir ; Wyka, Krystyna ; Tkaczyk, Marcin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-2360feaa94858d3a10b8b79fca1ee0fb5491d7069dfe404023e26a9b163cfae73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age groups</topic><topic>child</topic><topic>fibroblast growth factors</topic><topic>Fibroblasts</topic><topic>Growth factors</topic><topic>Pediatrics</topic><topic>renal insufficiency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stanczyk, Malgorzata</creatorcontrib><creatorcontrib>Chrul, Slawomir</creatorcontrib><creatorcontrib>Wyka, Krystyna</creatorcontrib><creatorcontrib>Tkaczyk, Marcin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Open medicine (Warsaw, Poland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stanczyk, Malgorzata</au><au>Chrul, Slawomir</au><au>Wyka, Krystyna</au><au>Tkaczyk, Marcin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum intact fibroblast growth factor 23 in healthy paediatric population</atitle><jtitle>Open medicine (Warsaw, Poland)</jtitle><addtitle>Open Med (Wars)</addtitle><date>2021-07-06</date><risdate>2021</risdate><volume>16</volume><issue>1</issue><spage>1022</spage><epage>1027</epage><pages>1022-1027</pages><issn>2391-5463</issn><eissn>2391-5463</eissn><abstract>It is believed that fibroblast growth factor 23 (FGF23) can become an early biomarker of chronic kidney disease progression. Data on FGF23 age dependency are inconsistent. We present the results of the cross-sectional study concerning FGF23 levels in healthy Polish children. This study was conducted in 121 children aged 0-18 years. Kidney function and intact FGF23 levels in serum were assessed. Differences between age groups and according to gender were analysed. The difference in FGF23 between age groups and according to gender was statistically insignificant. In the youngest and the oldest group, a trend to higher FGF23 levels was observed. FGF23 level in girls tended to be higher than boys, apart from the age group between 1 and 4 years. There was a negative correlation between eGFR and FGF23 ( = -0.26, &lt; 0.05) - strong in girls ( = -0.38, &lt; 0.05), but not in boys. In each age group, we found no significant correlation between eGFR and FGF23. Our study supports the evidence that the FGF23 level in paediatric population is not age or sex dependent. The results can serve as a reference point under clinical conditions and for other studies on the topic.</abstract><cop>Poland</cop><pub>De Gruyter</pub><pmid>34258392</pmid><doi>10.1515/med-2021-0288</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-6613-1642</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2391-5463
ispartof Open medicine (Warsaw, Poland), 2021-07, Vol.16 (1), p.1022-1027
issn 2391-5463
2391-5463
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_477ff00ad189485c8eae4f3d91cf778b
source PubMed Central; Walter De Gruyter: Open Access Journals
subjects Age groups
child
fibroblast growth factors
Fibroblasts
Growth factors
Pediatrics
renal insufficiency
title Serum intact fibroblast growth factor 23 in healthy paediatric population
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T18%3A55%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20intact%20fibroblast%20growth%20factor%2023%20in%20healthy%20paediatric%20population&rft.jtitle=Open%20medicine%20(Warsaw,%20Poland)&rft.au=Stanczyk,%20Malgorzata&rft.date=2021-07-06&rft.volume=16&rft.issue=1&rft.spage=1022&rft.epage=1027&rft.pages=1022-1027&rft.issn=2391-5463&rft.eissn=2391-5463&rft_id=info:doi/10.1515/med-2021-0288&rft_dat=%3Cproquest_doaj_%3E2548741532%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c464t-2360feaa94858d3a10b8b79fca1ee0fb5491d7069dfe404023e26a9b163cfae73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2548741532&rft_id=info:pmid/34258392&rfr_iscdi=true